Literature DB >> 6284888

Differential regulation of the mu-, delta-, and kappa-opiate receptor subtypes by guanyl nucleotides and metal ions.

A Pfeiffer, W Sadée, A Herz.   

Abstract

The effects of Na+, guanyl-5'-yl imidodiphosphate (Gpp(MH)p), and Mn2+ on the binding of dihydromorphine, ethylketocyclazocine, D-Ala2, D-Leu5-enkephalin, and diprenorphine to the opiate receptor were investigated. Three distinct binding sites, mu, delta, and kappa sites, were identified with the use of multiple tracer displacement curves. Moreover, this approach was used to determine the effects of Gpp (NH)p and metal ions on each individual binding site. At the mu and delta sites, Na+ and Gpp(NH)p each decreased and Mn2+ increased agonist binding affinities, with the exception of D-Ala2, D-Leu-enkephalin affinity which was not affected by Gpp(NH)p. None of these conditions markedly altered dihydromorphine and D-Ala2, Leu5-enkephalin binding to kappa sites, whereas the affinity of ethylke-tocyclazocine for kappa sites was decreased by Gpp(NH)p. Sodium ions lowered the capacity of mu sites and Gpp(NH)p reduced that of delta sites, while both agents increased the capacity of apparent kappa sites. These results demonstrate that each of the kinetically distinguishable binding sites is regulated differentially by metal ions and guanyl nucleotides. Simultaneous addition of Na+ and Gpp(NH)p greatly reduced the binding affinity of all three agonists at their respective high affinity sites (dihydromorphine at the mu site, D-Ala2, D-Leu5-enkephalin at the delta site, and ethylketocyclazocine at the kappa and mu sites). This result confirms previous observations that agonist binding is characterized by a large affinity reduction in the presence of both Na+ and guanyl nucleotides, and it extends this concept to each of the opiate receptor subtypes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6284888      PMCID: PMC6564396     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  6 in total

1.  Inhibition of dopamine-sensitive adenylate cyclase by opioids: possible involvement of physically associated mu- and delta-opioid receptors.

Authors:  A N Schoffelmeer; F Hogenboom; A H Mulder
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-03       Impact factor: 3.000

2.  Control by cations of opioid binding in guinea pig brain membranes.

Authors:  S J Paterson; L E Robson; H W Kosterlitz
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

3.  Visualization and solubilization of rat brain opiate receptors with a "kappa" ligand selectivity pattern.

Authors:  R Quirion; W D Bowen; M Herkenham; C B Pert
Journal:  Cell Mol Neurobiol       Date:  1982-12       Impact factor: 5.046

4.  Unexpected prosecretory action component of loperamide at mu-opioid receptors in the guinea-pig colonic mucosa in vitro.

Authors:  W Kromer
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

5.  Imaging endogenous opioid peptide release with [11C]carfentanil and [3H]diprenorphine: influence of agonist-induced internalization.

Authors:  Darren R Quelch; Loukia Katsouri; David J Nutt; Christine A Parker; Robin J Tyacke
Journal:  J Cereb Blood Flow Metab       Date:  2014-07-09       Impact factor: 6.200

6.  Pharmacological Characterization of Low-to-Moderate Affinity Opioid Receptor Agonists and Brain Imaging with 18F-Labeled Derivatives in Rats.

Authors:  Julian Ott; Mona M Spilhaug; Simone Maschauer; Waqas Rafique; Jimmy E Jakobsson; Karoline Hartvig; Harald Hübner; Peter Gmeiner; Olaf Prante; Patrick J Riss
Journal:  J Med Chem       Date:  2020-08-17       Impact factor: 7.446

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.